Home > Insider Trading > Filing (0001162956-18-000002)

Filing Details

Accession Number:: 0001162956-18-000002
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-08-21 20:57:57
Reporting Period:: 2018-08-14

Accepted Time:: 2018-08-21 20:57:57
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
926617	Vermillion Inc.	VRML	In Vitro & In Vivo Diagnostic Substances (2835)	330595156

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1162956	T James Lafrance	C/O Vermillion, Inc. 12117 Bee Caves Rd, Bldg 3 Ste 100 Austin TX 78738		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2018-08-14	2,573	$0.51	318,845	No	4	S	Direct
Common Stock	Disposition	2018-08-15	10,427	$0.49	301,418	No	4	S	Direct
Common Stock	Disposition	2018-08-17	7,500	$0.51	300,918	No	4	S	Direct
Common Stock	Disposition	2018-08-20	2,900	$0.54	298,018	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The sale reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.5150 to $0.5156 per share. The reporting person undertakes to provide to Vermillion, any security holder of Vermillion or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
The sale reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.4710 to $0.5150 per share. The reporting person undertakes to provide to Vermillion, any security holder of Vermillion or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
The sale reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.5059 to $0.5150 per share. The reporting person undertakes to provide to Vermillion, any security holder of Vermillion or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
The sale reported in column 4 is a weighted average price. The shares were sold in multiple transactions at $0.5375 per share. The reporting person undertakes to provide to Vermillion, any security holder of Vermillion or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.